Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment · Investor's Business Daily ALLISON GATLIN and ALAN R. ELLIOTT Mon, Jun 17, 2024, 1:06 PM 2 min read In This Article: NRIX +1.33% Nurix posted a "clear win" in leukemia treatment on Monday, but the biotech stock gave back some of its gains. Continue Reading View Comments Terms and Privacy Policy WA Consumer Health Privacy Policy Your privacy controls Recommended Stories